The World Health Organization warned Friday that the total global number of confirmed cases of coronavirus COVID-19 has nearly doubled in the past two months and is now nearing the highest rate since arrest early pandemic.
WHO Director-General Tedros Adhanom Ghebreyesus told reporters at a press conference: “Some countries that have previously avoided the widespread spread of covid-19 are now seeing a sharp increase in case of infection.
The number of cases is increasing in most regions, including the Americas, with India, Brazil, Poland and Turkey becoming the hot spot. Part of this increase is due to the new variants being more infectious than the original virus, experts say. But the gradual relaxation of restrictions in some places and overall pandemic fatigue are also contributing to this trend.
In the US, the Center for Disease Control and Prevention’s advisory committee said it would re-convene on April 23 to discuss clotting issues, prompting regulators to halt vaccine rollouts. by Johnson & Johnson.
Committee Gathered on Wednesday to review the data and trying to figure out why the six women who had been vaccinated developed a very rare clotting disorder, and voted to extend the “pause” and reconnect period to one day. later.
Much of the discussion focused on whether committee members need more clinical information before making a final recommendation or waiting to make a choice would further harm Americans at risk. acquired COVID-19.
J&J vaccine has been approved for emergency use by the US Food and Drug Administration in the context of controversy, as it is seen as an easier and fairer tool in the mass vaccination program. state as it only needs one injection and can be injected at people’s homes. or in mobile units. Other vaccines require two doses spaced several weeks apart and come with strict storage requirements.
The J&J vaccine also offers a spark of hope to the rest of the world, and especially to developing countries that are lagging behind in the race to get people vaccinated. United Nations and WHO have calls for rich countries not to use pig vaccines and has argued that doing so allows new variants to emerge, some of which may demonstrate resistance to existing vaccines.
The coagulation problem is also related to the vaccine developed by AstraZeneca PLC
and Oxford University, which have undermined vaccine confidence in a number of countries where people are already skeptical about them thanks to the legacy of colonialism and the dubious medical practices of local companies. West, New York Times reported.
In Malawi, people are asking doctors how to clear the AstraZeneca vaccine from their bodies, the paper reported on Friday. In South Africa, health officials have stopped providing JJ vaccinated, two months after discontinuing the AstraZeneca vaccine. And in the Democratic Republic of the Congo, 1.7 million doses of AstraZeneca were used, according to the Times.
CDC’s Dr. Sara Oliver told the advisory board that the Johnson & Johnson vaccine suspension “could have global impacts”.
Meanwhile, the US vaccine program continues to be making good progress. The Centers for Disease Control and Prevention’s vaccine tracker shows that as of 6 a.m. ET Thursday, 255.4 million doses had been delivered to the states, 198.3 million doses had been injected, and 125.8 million people had received at least one shot, equaling 37 , 9% of the population.
78.5 million people, or 23.6% of the population, were fully vaccinated, meaning they had received two doses of the two-dose vaccine provided by Pfizer Inc. develope.
and German partner BioNTech SE
single-shot vaccine. The AstraZeneca vaccine has not been approved for use in the United States
Among Americans 65 and older, 34.8 million were fully vaccinated, equaling 63.7% of that group. Nearly 44 million people of that age received an initial impact, comprising 80% of that population.
As reported by the New York Times, the US added at least 74,367 new cases on Thursday, and at least 912 people died. The US has recorded an average of 70,552 new cases per day over the past week, up 8% from the average two weeks ago.
The three top federal health officials – Dr. Anthony Fauci, head of the National Institute of Allergy and Infectious Diseases and President Joe Biden’s Medical Director; Dr. Rochelle Walensky, director of the CDC; and Dr. David Kessler, who runs the Biden administration’s vaccine effort – urged Americans to continue to schedule appointments and vaccinations at a Capitol Hill hearing on Thursday.
Kessler seeks to alleviate vaccine concerns by reminding Americans that licensed vaccines have a “great safety record”. The six J&J vaccine-related coagulation cases are a very small number compared with the 6.8 million people who received the shot at the announcement of the suspension, experts emphasize.
In other news
• Pfizer CEO Albert Bourla said it is likely that recipients of Covid-19 vaccine will need a booster shot within the following year, and then annual vaccination, to maintain protection against virus as it grows, The Wall Street Journal reported. “The variations will play an important role. Bourla said in a virtual event hosted by CVS Health Corp is critically important.
“There are vaccines like polio,” says Bourla. “Just one dose is enough.” “And there are flu-like vaccines that you need every year. The Covid virus looks more like an influenza virus than a polio virus ”.
• Eli Lilly & Co.
is seeking to revoke an emergency license issued by US regulators for the treatment of bamlanivimab antibodies to a single COVID-19 to complete the transition to bamlanivimab and etesevimab together. “Lilly made this request due to the growing variation in the United States and the full availability of bamlanivimab and etesevimab together,” the company said in a statement. This combination has been shown to be more effective in neutralizing the COVID-19 variant that was discovered in the US after its first appearance in the UK, South Africa and Brazil, and potentially infectious. stronger than the original virus. This combination is also better in the treatment of the rapidly growing California strain B.1.427 / B.1.429 which currently accounts for 50% of viral cases in California and more than 10% of cases in other states.
• The Norwegian government has rejected advice from the country’s public health agency about the permanent removal of the drug company AstraZeneca’s vaccine from its vaccination program, saying it needs more time to decide whether to start using the injection again, MarketWatch’s Lina Saigol reported. Norwegian Institute of Public Health (FHI) On Thursday they recommended an end to the use of the shot, saying they now have enough information on “the link between the AstraZeneca vaccine and the rare and serious incidents of low platelets, blood clots and bleeding.” blood ”to draw conclusions. Proposal came a day later Denmark became the first country to permanently stop using AstraZeneca’s shot, after its own assessment, has found a probable association with very rare cases of blood clots. Several other European countries have Use restrictions vaccines for certain age groups.
• India recorded a few more record COVID-19 cases on Friday, when hundreds of thousands of Hindus attended a week-long festival that kept people in close contact, Reuters reported. Hospitals are running out of oxygen and beds, even after authorities restricted movement of people in Mumbai, New Delhi and other cities. India recorded 217,353 new cases on Friday, marking the eighth daily record increase in the past nine days. India has nearly 14.3 million cases of COVID, second only to the US
• J&J contacted rival COVID vaccine manufacturers to join an effort to study clotting risks and address safety concerns with one voice, but Pfizer and Moderna declined the offer. hey, The Wall Street Journal reported. The executives of Pfizer and Moderna said the vaccine appeared to be safe, the paper reported, citing people familiar with the matter. The pair also protested because they did not see the need to duplicate the efforts of regulators and companies that have searched for cases of blood clots and investigated the cause, they said. One company’s concern: The security of Pfizer and Moderna photos could be affected by the association, some people said. Only AstraZeneca, which has suffered from similar clotting concerns for weeks, agreed, the men said.
According to global statistics on the disease caused by coronavirus increased over 139 million on Friday, according to data compiled by Johns Hopkins University, when the number of deaths increased to over 2.98 million.
More than 79 million people have recovered from COVID, data show.
The United States leads the world in terms of morbidity and mortality in a wide margin, with 31.5 million cases accounting for about 23% of the global population, while 565,299 deaths account for about 19% of all global deaths.
India ranked fourth globally with a death toll of 174,308.
Brazil ranked third in cases with 13.7 million people and second with a death toll of 365,444.
Mexico ranked third in the number of deaths with 211,213 people and the 14th highest in the number of cases with 2.3 million people.
The UK has 4.4 million cases and 127,438 deaths, the highest in Europe and the fifth highest in the world.
China, where the virus was first detected late last year, There have been 102,152 confirmed cases and 4,845 deaths, according to its official figures.
What does the economy say?
New home construction surged after winter weather caused a slowdown in February, at a time when the housing market desperately needs more inventory to meet growing demand from first-time buyers. , MarketWatch’s Jacob Passy reported.
US housing builders started building housing at a seasonally adjusted annual rate of 1.74 million in March, up 19% from last month’s rising revision figures, Bureau of Regulatory Authority. census of the United States fourth report. Compared to March 2020, the number of housing starts to increase significantly by 37%.
The rate of allowing new housing units also increased in March, albeit with fewer numbers. Licensing for new homes occurred at a seasonally adjusted annual rate of 1.77 million, up 2.7% from February and 30% from a year ago.
Economists polled by MarketWatch have predicted housing will begin to emerge at a rate of 1.62 million and construction permits will arrive at a rate of 1.75 million.
Dow Jones industrial average
and S&P 500